Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Discover KolateAI's innovative platform that leverages AI and real-world data to optimize clinical trials and drug development. Empowering…
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
NeuraLight51-200 employees
Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.
Nucleai helps biopharma answer two critical questions: why does a therapy work, and which patients will benefit?
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
Sequence Bio11-50 employees
We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from…

Overview

Analyst-grade AI system that answers complex questions across millions of references to optimize drug development and clinical trials.

News

Report
Report
Press release PRNewswire 8 years ago
AT&T and Clairvoyant Networks Unveil Theora Care Solutions at HIMSS
/PRNewswire/ -- Clairvoyant Networks, LLC, chose AT&T to provide connectivity to its new line of caregiver solutions, Theora Care. An AT&T SIM transmits data...
Read more
Report
Pro access
Upgrade to see all 38 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.